Liu J - Search Results

1

HDAC5, negatively regulated by miR-148a-3p, promotes colon cancer cell migration.

OuYang C, Shu G, Liu J, Deng S, Lu P, Li Y, Gan Y, Xie B, Liu J, Yin G. OuYang C, et al. Among authors: liu j. Cancer Sci. 2022 Aug;113(8):2560-2574. doi: 10.1111/cas.15399. Epub 2022 Jun 5. Cancer Sci. 2022. PMID: 35574707 Free PMC article.

2

EN2 as an oncogene promotes tumor progression via regulating CCL20 in colorectal cancer.

Li Y, Liu J, Xiao Q, Tian R, Zhou Z, Gan Y, Li Y, Shu G, Yin G. Li Y, et al. Among authors: liu j. Cell Death Dis. 2020 Jul 30;11(7):604. doi: 10.1038/s41419-020-02804-3. Cell Death Dis. 2020. PMID: 32732864 Free PMC article.

3

MEF2A transcriptionally upregulates the expression of ZEB2 and CTNNB1 in colorectal cancer to promote tumor progression.

Xiao Q, Gan Y, Li Y, Fan L, Liu J, Lu P, Liu J, Chen A, Shu G, Yin G. Xiao Q, et al. Among authors: liu j. Oncogene. 2021 May;40(19):3364-3377. doi: 10.1038/s41388-021-01774-w. Epub 2021 Apr 16. Oncogene. 2021. PMID: 33863999 Free PMC article.

4

Identification of ZNF26 as a Prognostic Biomarker in Colorectal Cancer by an Integrated Bioinformatic Analysis.

Liu J, Li Y, Gan Y, Xiao Q, Tian R, Shu G, Yin G. Liu J, et al. Front Cell Dev Biol. 2021 Jun 11;9:671211. doi: 10.3389/fcell.2021.671211. eCollection 2021. Front Cell Dev Biol. 2021. PMID: 34178996 Free PMC article.

5

Metformin suppresses the growth of colorectal cancer by targeting INHBA to inhibit TGF-β/PI3K/AKT signaling transduction.

Xiao Q, Xiao J, Liu J, Liu J, Shu G, Yin G. Xiao Q, et al. Among authors: liu j. Cell Death Dis. 2022 Mar 2;13(3):202. doi: 10.1038/s41419-022-04649-4. Cell Death Dis. 2022. PMID: 35236827 Free PMC article.

6

Downregulation of MEIS1 mediated by ELFN1-AS1/EZH2/DNMT3a axis promotes tumorigenesis and oxaliplatin resistance in colorectal cancer.

Li Y, Gan Y, Liu J, Li J, Zhou Z, Tian R, Sun R, Liu J, Xiao Q, Li Y, Lu P, Peng Y, Peng Y, Shu G, Yin G. Li Y, et al. Among authors: liu j. Signal Transduct Target Ther. 2022 Mar 30;7(1):87. doi: 10.1038/s41392-022-00902-6. Signal Transduct Target Ther. 2022. PMID: 35351858 Free PMC article.

7

A 13-Gene Signature Based on Estrogen Response Pathway for Predicting Survival and Immune Responses of Patients With UCEC.

Li Y, Tian R, Liu J, Ou C, Wu Q, Fu X. Li Y, et al. Among authors: liu j. Front Mol Biosci. 2022 Apr 26;9:833910. doi: 10.3389/fmolb.2022.833910. eCollection 2022. Front Mol Biosci. 2022. PMID: 35558564 Free PMC article.

8

Deciphering the immune landscape dominated by cancer-associated fibroblasts to investigate their potential in indicating prognosis and guiding therapeutic regimens in high grade serous ovarian carcinoma.

Li Y, Tian R, Liu J, Li J, Tan H, Wu Q, Fu X. Li Y, et al. Among authors: liu j. Front Immunol. 2022 Sep 2;13:940801. doi: 10.3389/fimmu.2022.940801. eCollection 2022. Front Immunol. 2022. PMID: 36119108 Free PMC article.

9

Identification of CPT2 as a prognostic biomarker by integrating the metabolism-associated gene signature in colorectal cancer.

Liu J, Li Y, Xiao Q, Li Y, Peng Y, Gan Y, Shu G, Yi H, Yin G. Liu J, et al. BMC Cancer. 2022 Oct 4;22(1):1038. doi: 10.1186/s12885-022-10126-0. BMC Cancer. 2022. PMID: 36195841 Free PMC article.

10

Integrative evaluation and experimental validation of the immune-modulating potential of dysregulated extracellular matrix genes in high-grade serous ovarian cancer prognosis.

Wu Q, He X, Liu J, Ou C, Li Y, Fu X. Wu Q, et al. Among authors: liu j. Cancer Cell Int. 2023 Sep 30;23(1):223. doi: 10.1186/s12935-023-03061-y. Cancer Cell Int. 2023. PMID: 37777759 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

147,585 results

Search Page

Filters